Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 8, 2022
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
[ Thu, Sep 08th 2022
] - WOPRAI
Neena Bitritto-Garg Maintained (AMLX) at Strong Buy with Increased Target to $48 on, Sep 8th, 2022
Neena Bitritto-Garg of Citigroup, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Increased Target from $35 to $48 on, Sep 8th, 2022.
Neena, nor any peers, have made any analyst calls on AMLX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30